CIRM Oversight Panel Recommends More Accountability, Transparency at Agency
The California state panel charged with overseeing financial practices at the state's $3 billion stem cell research agency today urged it to improve its accountability and make its performance more open to the public.
State Controller John Chiang, the state's top fiscal officer and chairman of the panel, said,
“Californians overwhelmingly voted in 2004 to…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.